Cure stuttering: with Vivavoce you can
06 September 2019
BALBUZIE
VOCE
DISTURBI LINGUAGGIO
Amedical centre specialising in the treatment of stuttering, Vivavoce aims to become a point of reference in Italy and abroad for thetreatment of this disorder and, more generally, for all disorders related to language and communication.
In less than a week from the launch, it has already collected over € 100,000 of adhesions, reaching 67% of the collection.
DISCOVER THE VIVAVOCE CAMPAIGN
The founder of the company, Giovanni Muscarà, suffering from stuttering since childhood, has always strongly believed in the project: together with a clinical and scientific team of primary importance, he has developed an innovative method for the treatment of stuttering, the MRM-S (Muscarà Rehabilitation Method for Stuttering), now scientifically proven and among the few methods in the world to have strong scientific evidence.
A method that convinced private investors and the regional development fund LigurCapital Spa to participate in the first round of financing of the company in 2015, with a capital increase of € 342 thousand. Thanks to these resources, Vivavoce's turnover has increased from € 54 thousand in 2015 to almost € 500 thousand expected by the end of 2019 and the company has been able to demonstrate the potential of the method developed: new patients have increased from 35 in 2015 to 200 expected by the end of 2019, with a satisfaction rate of 99%.
Stuttering is unfortunately a widespread disorder: in Europe, in fact, more than 11 million people suffer from it, of which 1 million in Italy alone.
It is a disorder that is often underestimated, erroneously attributed to moods such as anxiety or shyness, but which actually has a strong social impact, because those who suffer from it are much more exposed to the risk of bullying and discrimination at work.
In a fragmented context, where there is a lack of a commonly recognized center of excellence, Vivavoce aims to become the most important and authoritative center to improve the lives of people suffering from voice disorders.
Warnings pursuant to art. 19 para. 2
the crowdfunding services provided by Mamacrowd do not fall under the deposit guarantee scheme established in accordance with Directive 2014/49/EU; the securities and instruments eligible for crowdfunding that can be acquired through this crowdfunding platform do not fall under the investor compensation scheme established in accordance with Directive 97/9/EC.
© 2024 Mamacrowd Srl a company of Azimut Group - VAT number IT07464370969 - Via Timavo 34, 20124 MI - SC € 95.417,54 fully paid up - Crowdfunding service provider authorised by resolution No. 22876 of 08/11/2023